Glenmark Pharmaceuticals Ltd has received final approval from the
United States Food and Drug Administration (USFDA) for Topiramate
extended-release capsules USP in the strengths of 25 mg, 50 mg, 100
mg, 150 mg, and 200 mg, Glenmark said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-seizure-treatment-drug/articleshow/80662988.cms
No comments:
Post a Comment